loading...
Multimodal Polymeric Contrast Agents for MRI and Fluorescence Imaging in the Management of Cancer.
Washington, DC October 19-October 21
DOI Bookmark: http://doi.ieeecomputersociety.org/10.1109/AIPR.2005.3634th Applied Imagery and Pattern Reco ...
 This Article 
 
PDF
HTML
 
 Share 
   
 Bibliographic References 
   
 Add to: 
 
Digg
Furl
Spurl
Blink
Simpy
Google
Del.icio.us
Y!MyWeb
 
 Search 
   
Egidijus E. Uzgiris, General Electric Global Research
Deborah Lee, General Electric Global Research
Anup Sood, General Electric Global Research
Kathleen Bove, General Electric Global Research
Steve Lomnes, General Electric Global Research
Macromoleular contrast agents in MRI have been used widely in pre-clinical studies. They have been very effective in determining two hemodynamic parameters that correlate strongly with tumor grade: tumor blood volume and tumor permeability ^1. Thus, determining either of these parameters may be a useful indicator for tumor prognosis ^1-3 and tumor response to therapy ^4-6. We pose the following question: Can optical imaging of accessible tumors, i.e., in studies of subcutaneous tumors, be used in a way as to evaluate either of these parameters? We present preliminary data that suggest that a simple experimental protocol can provide at least an index of the permeability parameter if not the absolute permeability itself.
Citation:
Egidijus E. Uzgiris, Deborah Lee, Anup Sood, Kathleen Bove, Steve Lomnes, "Multimodal Polymeric Contrast Agents for MRI and Fluorescence Imaging in the Management of Cancer.," aipr, pp.133-139, 34th Applied Imagery and Pattern Recognition Workshop (AIPR'05), 2005
Usage of this product signifies your acceptance of the Terms of Use.